Endogenous Ligand Competition

Why Endogenous Ligand Competition Matters

A drug can bind its intended receptor and still occupy only part of the available receptor population. If an endogenous ligand also binds the same site, some receptors are bound by that ligand rather than by the drug. The extent of this competition depends on both ligands’ free concentrations and their affinities; concentration alone is not enough to predict occupancy.

The equations below describe a single receptor population with one shared binding site. They quantify binding, not the functional effect of either ligand. In particular, occupancy by an endogenous ligand does not by itself specify whether that ligand activates, inhibits, or otherwise changes a downstream response.

Definition: Let \(R\) be free receptor, \(D\) free drug, and \(L\) free endogenous ligand. Let \(RD\) and \(RL\) denote their respective receptor complexes. The equilibrium dissociation constants are \(K_D=[R][D]/[RD]\) and \(K_L=[R][L]/[RL]\). Drug occupancy is the fraction of total receptor bound by drug, \(\theta_D=[RD]/R_T\), where \(R_T=[R]+[RD]+[RL]\).

This model assumes reversible 1:1 binding at equilibrium, mutually exclusive binding to the same site, and one homogeneous receptor population. The concentrations in the equilibrium equations are free concentrations. The model also assumes that the stated dissociation constants apply under the conditions being analyzed and that binding does not change receptor abundance or create additional binding states. These assumptions should be checked before interpreting the calculated occupancy.

Shared-Site Occupancy at Fixed Free Concentrations

At equilibrium, the mass-action relations give \([RD]=[R][D]/K_D\) and \([RL]=[R][L]/K_L\). Substituting these into the receptor balance gives the fractions of receptors in each state:

\theta_D=\frac{[RD]}{R_T} =\frac{[D]/K_D}{1+[D]/K_D+[L]/K_L}, \qquad \theta_L=\frac{[L]/K_L}{1+[D]/K_D+[L]/K_L}.

The remaining fraction is unbound: \(\theta_R=1/(1+[D]/K_D+[L]/K_L)\). The three fractions sum to one. The terms \([D]/K_D\) and \([L]/K_L\) are dimensionless measures of binding drive, so a ligand’s contribution depends on its free concentration relative to its own dissociation constant.

If free concentrations are maintained by large reservoirs, the expression can also be written as a drug occupancy curve with an apparent dissociation constant:

\theta_D =\frac{[D]}{[D]+K_D\left(1+[L]/K_L\right)}, \qquad K_{D,\mathrm{app}}=K_D\left(1+[L]/K_L\right).

The apparent value increases as the endogenous ligand’s free concentration increases. This is a competitive shift in the concentration-occupancy relationship, not a change in the drug’s intrinsic \(K_D\). If endogenous ligand is absent, \([L]=0\), and the usual one-ligand equilibrium relation is recovered.

Worked Example: Comparing Drug Occupancy With and Without Endogenous Ligand

Suppose free drug is \(3.00\) nM and its \(K_D\) is \(2.00\) nM. Free endogenous ligand is \(8.00\) nM and its \(K_L\) is \(4.00\) nM. Assume both free concentrations are maintained and the shared-site equilibrium assumptions hold. Calculate drug occupancy and compare it with occupancy in the absence of endogenous ligand.

The dimensionless binding terms are \([D]/K_D=3.00/2.00=1.50\) and \([L]/K_L=8.00/4.00=2.00\). Therefore,

\theta_D=\frac{1.50}{1+1.50+2.00} =\frac{1.50}{4.50} =0.3333.

Thus, \(33.33\%\) of receptors are drug-bound under these conditions. Without endogenous ligand, the occupancy would be \(1.50/(1+1.50)=0.6000\), or \(60.00\%\). The absolute decrease is \(0.6000-0.3333=0.2667\), a decrease of 26.67 percentage points. Relative to the no-endogenous-ligand occupancy, the decrease is \(0.2667/0.6000=44.45\%\). These comparisons hold the free drug concentration fixed; they do not imply the same result if drug is depleted from a finite pool.

Finite Totals: Binding Changes Free Concentrations

In a finite-target system, drug and endogenous ligand bound to receptors are no longer free in solution. Their total concentrations therefore cannot simply be substituted for \([D]\) and \([L]\) in the fixed-free-concentration formula. Let \(D_T\), \(L_T\), and \(R_T\) be the total drug, total endogenous ligand, and total receptor concentrations. The balances are:

D_T=[D]+[RD],\qquad L_T=[L]+[RL],\qquad R_T=[R]+[RD]+[RL].

Together with \([RD]=[R][D]/K_D\) and \([RL]=[R][L]/K_L\), these equations form a binding balance. For a proposed free receptor concentration, the ligand balances can be rearranged to give \([D]=D_T/(1+[R]/K_D)\) and \([L]=L_T/(1+[R]/K_L)\). Substitution into the receptor balance gives a single equation in \([R]\). Solve for a physically meaningful root, then recover the complexes and occupancy. A numerical root finder is often convenient, but each solution must satisfy all three balances and have nonnegative concentrations.

Worked Example: Solving a Symmetric Finite-Total Binding Balance

Consider a hypothetical system with \(R_T=D_T=L_T=10.0\) nM and \(K_D=K_L=1.00\) nM. The ligands have identical totals and affinities, so at equilibrium their free concentrations are equal; call each \(x\). The receptor balance gives \([R]=10.0/(1+2x)\), and the bound concentration of either ligand is \([R]x/K_D=10.0x/(1+2x)\). Apply the drug total balance:

10.0=x+\frac{10.0x}{1+2x} \quad\Longrightarrow\quad 2x^2-9x-10=0.

The positive root is \(x=(9+\sqrt{161})/4\approx5.4221444\) nM. The other root is negative and cannot represent a concentration. Drug occupancy is the drug-bound concentration divided by total receptor:

\theta_D=\frac{[RD]}{R_T} =\frac{x}{1+2x} =\frac{5.4221444}{1+2(5.4221444)} \approx0.4578.

The corresponding bound drug concentration is \(10.0(0.4577856)\approx4.5779\) nM. Free plus bound drug is approximately \(5.4221+4.5779=10.000\) nM, consistent with the \(10.0\) nM total. The same balance holds for the endogenous ligand. The receptor balance also checks: free receptor is \(10.0/(1+2x)\approx0.8443\) nM, and \(0.8443+4.5779+4.5779\approx10.000\) nM. This illustrates why total concentration cannot be used as free concentration when receptor binding depletes the ligand pools.

How Much Drug Is Needed for a Target Occupancy?

At fixed free endogenous ligand concentration, the occupancy equation can be rearranged to find the free drug concentration needed for a specified occupancy. Starting with \(\theta_D=a/(1+a+q)\), where \(a=[D]/K_D\) and \(q=[L]/K_L\), multiply both sides by the denominator and collect terms in \(a\):

\theta_D(1+a+q)=a \quad\Longrightarrow\quad a=\frac{\theta_D}{1-\theta_D}(1+q), \qquad [D]=K_D\frac{\theta_D}{1-\theta_D}\left(1+\frac{[L]}{K_L}\right).

This derivation requires \(0<\theta_D<1\). For a target occupancy below one, higher endogenous ligand binding drive requires proportionally more free drug under the fixed-free-ligand assumptions. In a finite-total system, this result determines a required free drug concentration; the total dose or concentration must additionally account for drug bound to receptor and other relevant sinks.

Worked Example: Adjusting Free Drug for a Target Occupancy

Suppose \(K_D=2.00\) nM, the target drug occupancy is \(0.400\), and free endogenous ligand has \([L]/K_L=3.00\). Assume free endogenous ligand is held constant and the equilibrium assumptions are satisfied. The required free drug concentration is:

[D]=2.00\ \mathrm{nM}\times\frac{0.400}{1-0.400}\times(1+3.00) =2.00\times\frac{2}{3}\times4.00\ \mathrm{nM} =5.333\ \mathrm{nM}.

Without endogenous ligand, the required free drug concentration would be \(2.00\times(2/3)=1.333\) nM. The fourfold difference follows from the factor \(1+[L]/K_L=4.00\). It is a comparison of free concentrations in this model, not a claim that a clinical dose must increase fourfold: distribution, depletion, and other pharmacokinetic processes can change the relationship between dose and free concentration.

Diagnostics, Comparisons, and Limitations

A useful diagnostic is to verify the occupancy accounting. Under the shared-site model, \(\theta_D\), \(\theta_L\), and \(\theta_R\) must each lie between zero and one and sum to one. For finite totals, calculated free and bound concentrations must also reproduce \(D_T\), \(L_T\), and \(R_T\). A negative concentration, a fraction outside this range, or a balance that fails beyond rounding indicates an algebraic, numerical, or unit error.

The fixed-free-concentration equation is most appropriate when free ligand concentrations are known or effectively buffered. The finite-total balance is needed when receptor binding materially depletes either ligand pool. The latter requires total concentrations and both affinities, and generally needs a simultaneous solution; inserting totals directly into the fixed-free equation can overstate binding drive. If a measured occupancy does not agree with either model, possible explanations include failure to reach equilibrium, inaccurate free concentration or affinity estimates, receptor heterogeneity, or binding behavior inconsistent with a single mutually exclusive site. These are reasons to reassess assumptions rather than to force a fit by changing the intrinsic \(K_D\).

The formula also gives a direct qualitative check: at fixed free drug concentration, increasing \([L]/K_L\) lowers drug occupancy. In fact, writing \(a=[D]/K_D\) and \(q=[L]/K_L\), the derivative is \(\partial\theta_D/\partial q=-a/(1+a+q)^2<0\) when \(a>0\). If a calculation predicts the opposite under these fixed-free conditions, the competition terms have likely been assigned incorrectly. This monotonic result does not imply that changing endogenous ligand in a living system changes only \(q\); feedback, ligand production, and free concentrations may also change.

Key takeaway: At a shared equilibrium binding site, occupancy is determined by each ligand’s free concentration divided by its dissociation constant. Endogenous ligand reduces drug occupancy by contributing to the same receptor-state balance. When ligand or receptor totals are finite, solve the mass balances for free concentrations before interpreting occupancy.

Check Your Understanding

Answer each question, then compare your reasoning with the solutions below.

At fixed free concentrations, \([D]/K_D=2.00\) and \([L]/K_L=1.00\). What is drug occupancy?
For \([D]/K_D=1.00\), how does drug occupancy change as \([L]/K_L\) rises from \(0\) to \(2.00\)?
Why is it generally incorrect to substitute total drug concentration for free drug concentration in the shared-site occupancy equation?
At fixed free endogenous ligand, what factor multiplies the no-endogenous-ligand free drug concentration needed to achieve a given occupancy?

Solutions. (1) \(\theta_D=2.00/(1+2.00+1.00)=0.5000\), so half the receptors are drug-bound. (2) At \(q=0\), occupancy is \(1/(1+1)=0.5000\); at \(q=2.00\), it is \(1/(1+1+2)=0.2500\). (3) Some total drug may be receptor-bound, so the free concentration entering the equilibrium relation is less than the total; the finite-total balance must account for that bound pool. (4) The factor is \(1+[L]/K_L\), as follows from rearranging the occupancy equation for \([D]\).

What You'll Learn